Rezolute RZLT
NASDAQ RZLT
$3.89 +0.04 (+0.91%)
As of: Oct 23, 2026 · 2:17 PM EDT

Rezolute (RZLT) Return on Sales [ROS] (2019 - 2020)

Updated

Analysis

Rezolute (RZLT) Return on Sales [ROS] (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,127.42 Bn 1,096.00 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 633.77 Bn 553.63 Bn 17.30 Bn 24.35%
3 AbbVie 505.19 Bn 478.30 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 290.00 Bn 253.99 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.19 Bn 238.88 Bn 12.86 Bn 20.57%
7 Amgen 238.02 Bn 193.42 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -133.21%
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 28.37%
10 Rezolute 404.72 Mn -108.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -120,766.67%
Jun 30, 2020 -71,040.00%
Mar 31, 2020 -16,900.00%
Dec 31, 2019 -12,444.44%
Jun 30, 2019 -6,497.96%
Mar 31, 2019 -141,975.00%
API Access

Rezolute Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RZLT&period=max&api_key=YOUR_API_KEY